Crossmark

Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial

Crossref DOI link: https://doi.org/10.1038/s41467-026-69315-1

Published Online: 2026-02-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Xun https://orcid.org/0000-0003-1617-1501
Zhou, Jia-Yu

Huang, Hao-Yang

Guo, Ling

Huang, Ying-Ying

Qiu, Wen-Ze

Lin, Zhuo-Chen

Cao, Ka-Jia

Mo, Hao-Yuan

Li, Xian-Ming

Li, Zi-Huang

Han, Fei

He, Yu-Xiang

Liu, Yu-Meng

Bai, Yong-Rui

Wu, Shao-Xiong

Ke, Liang-Ru https://orcid.org/0000-0001-7927-9726
Chen, Xi https://orcid.org/0000-0002-8259-9509
Liang, Chi-Xiong

Luo, Zhuo-Ying

Xia, Yue

Deng, Ying

Miao, Jing-Jing

Xia, Wei-Xiong

Liang, Hu

Zhao, Chong https://orcid.org/0000-0003-3271-5783
Xiang, Yan-Qun https://orcid.org/0000-0003-4334-3794
Guo, Xiang

Lv, Xing https://orcid.org/0000-0003-3125-6853
Funding

Funding for this research was provided by:

Natural Science Foundation of Guangdong Province (2021A1515010118)
License Information

Text and Data Mining valid from 2026-02-10

Version of Record valid from 2026-03-19
More Information

Article History

Received: 29 July 2025

Accepted: 26 January 2026

First Online: 10 February 2026

Competing interests

: The author declare no competing interests.

Document is current

Any future updates will be listed below